NuCana PLC (NCNA)
3.85
-0.11
(-2.78%)
USD |
NASDAQ |
May 01, 16:00
3.85
0.00 (0.00%)
After-Hours: 20:00
NuCana Shareholders Equity (Quarterly): 18.96M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 18.96M |
September 30, 2023 | 26.57M |
June 30, 2023 | 34.54M |
March 31, 2023 | 39.33M |
December 31, 2022 | 46.60M |
September 30, 2022 | 58.84M |
June 30, 2022 | 67.96M |
March 31, 2022 | 77.13M |
December 31, 2021 | 88.47M |
September 30, 2021 | 103.99M |
June 30, 2021 | 116.52M |
March 31, 2021 | 125.71M |
December 31, 2020 | 135.23M |
September 30, 2020 | 141.85M |
Date | Value |
---|---|
June 30, 2020 | 70.32M |
March 31, 2020 | 74.76M |
December 31, 2019 | 83.29M |
September 30, 2019 | 86.30M |
June 30, 2019 | 92.54M |
March 31, 2019 | 99.97M |
December 31, 2018 | 103.53M |
September 30, 2018 | 110.58M |
June 30, 2018 | 113.36M |
March 31, 2018 | 122.56M |
December 31, 2017 | 126.25M |
June 30, 2017 | 27.82M |
December 31, 2016 | 31.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.96M
Minimum
Dec 2023
141.85M
Maximum
Sep 2020
78.36M
Average
77.13M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 39.51M |
Biodexa Pharmaceuticals Plc | 5.959M |
Autolus Therapeutics PLC | 111.47M |
Mereo BioPharma Group PLC | 50.54M |
Bicycle Therapeutics PLC | 370.93M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 35.43M |
Total Liabilities (Quarterly) | 16.46M |